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Abstract
Purpose The purpose of the study is to investigate screening
in follow-up care to identify head and neck cancer (HNC)
patients with untreated psychological distress.
Methods From November 2009 until December 2012, we in-
vestigated the use of OncoQuest (a touch screen computer
system to monitor psychological distress (Hospital Anxiety
and Depression Scale (HADS)) and quality of life (HRQOL;
EORTC QLQ-C30 and H&N35 module) in routine follow-up
care. Patients who screened positive for psychological distress
(HADS-T >14, HADS-A >7, or HADS-D >7) were asked
whether they received psychological or psychiatric treatment.
Results During the study period of 37 months, OncoQuest
was used by 720 individual HNC patients, of whom 714 had
complete HADS data. Psychological distress was present in
206 patients (29 %). Of those patients who fulfilled in- and
exclusion criteria (n=137), 25 received psychological treat-
ment (18 %). Receipt of psychological treatment was signifi-
cantly related to a higher score on the HADS total scale (19.6
vs. 16.9; p=0.019), a lower (worse) score on the EORTC
QLQ-C30 scale emotional functioning (46.0 vs. 58.6;
p=0.023), a higher (worse) score on fatigue (58.2 vs. 46.4;
p=0.032), problems with sexuality (44.1 vs. 34.4; p=0.043),
oral pain (43.8 vs. 28.8; p=0.011) and speech problems (37.0
vs. 25.3; p=0.042).
Conclusions Screening for psychological distress via
OncoQuest is beneficial because 82 % of HNC patients iden-
tified with an increased level of distress who do not yet receive
mental treatment were identified. Patients who did receive
treatment reported more distress and worse quality of life,
which may be explained because patients with more severe
problems maybe more inclined to seek help or might be de-
tected easier by caregivers and referred to supportive care
more often.
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Introduction
Psychosocial care is increasingly recognised as an integral
part of quality cancer treatment [1]. In the Netherlands, gov-
ernment policy statements, various cancer specific guidelines,
reflect broad scientific and societal support for a structured,
integrated approach to psychosocial care for cancer patients
[2, 3]. Although there is evidence that psychosocial care is
effective [4–6], referral rates are low [7, 8], and many patients
have unmet needs, related to e.g. fatigue, sexuality issues and
life stress [9–11]. The identification and support of cancer
patients with psychological distress is a challenge [10, 12],
especially in head and neck cancer (HNC) patients as they
do not usually express their emotions spontaneously in front
of the oncologists. One of the main barriers to deliver psycho-
social cancer care in cancer patients is lack of screening for
psychological distress in clinical practice to identify patients
[13–16].
Fitch [15] stated that the need for identifying psychological
distress is clear and there are suitable patient reported outcome
measures (PROMs) available to perform this screening. The
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Distress Thermometer with the accompanying problem list is
often used for assessment of each patient’s unique needs [3,
17]. Other tools have emerged as well, such as Viewpoint
[18], SupportScreen [19], ESRA-C [20], and CHES [21]. At
the Department of Otolaryngology-Head and Neck Surgery of
VUUniversity Medical Center, efficient screening for distress
followed by triage to care has become available in 2006 by a
touch screen computer system (OncoQuest) that was imple-
mented in routine clinical practice [7, 22, 23]. Via OncoQuest,
patients complete quality of life (HRQOL) questionnaires
(EORTC QLQ-C30 and condition-specific modules such as
the EORTC QLQ-H&N35) and the Hospital Anxiety and De-
pression Scale (HADS) [23]. OncoQuest is linked to the hos-
pital patient information system. Data are processed in real-
time and a care coordinator (a nurse specialised in HNC) can
view the results by clear graphics on a computer in the con-
sulting room and discuss these with the patient. In this pro-
spective surveillance model, HRQOL can be repeatedly mon-
itored and changes can be assessed; physical impairment,
functional limitations and psychosocial distress can be identi-
fied in an early stage, information and psychoeducation can be
provided, and, if necessary, supportive care including rehabil-
itation, psychosocial care and healthy lifestyle programs can
be introduced.
Several studies have shown that using PROMs facilitates
communication about patients’ symptoms, functioning and
distress between doctors, nurses and patients [16]. However,
an international debate has emerged concerning screening for
psychological distress in clinical practice with authors with
solid arguments in favour of screening [12, 16, 24–27] and
other authors with valid arguments against it [28–30]. For
instance, Palmer et al. [29] reported that 36 % of recently
diagnosed breast cancer patients with elevated distress or a
psychiatric disorder already received psychotropic medica-
tion. The authors argued that because of this relatively high
percentage, screening all breast cancer patients is therefore not
very effective. However, information on patients with other
types of cancer is scarce, which hampers the discussion on
pros and cons of screening for distress in clinical practice.
The aim of this study is to investigate screening in follow-
up care to identify HNC patients with untreated psychological
distress. Furthermore, sociodemographic and clinical factors
and HRQOL outcomes will be investigated that may be asso-
ciated with untreated psychological distress.
Materials and methods
Study population
All patients who routinely visited our outpatient clinic for
follow-up care within a time frame of 37 months (November
2009–December 2012) were screened for psychological
distress as part of standard clinical care. Patients who screened
positive for psychological distress (HADS-T >14, HADS-A
>7, or HADS-D >7) were assessed for eligibility for this cross-
sectional study and, when eligible, asked to participate in one
interview on whether they received psychiatric or psycholog-
ical treatment, and if so, which type of treatment. Eligible
patients were those who were treated for cancer at least
1 month to 15 years earlier in VU University Medical Center
for carcinoma of the lip, oral cavity, oropharynx, hypophar-
ynx, nasopharynx, larynx or salivary glands (all stages), and
who were treated with curative intent (all treatment modali-
ties). Exclusion criteria were other (neurological) diseases
causing cognitive dysfunction, end of treatment for a psychi-
atric disorder less than 2 months ago or being under treatment
for another psychiatric disorder, not being reachable, insuffi-
cient knowledge of the Dutch language to fill out the ques-
tionnaires, and incomplete HADS data. Sociodemographic
(age, gender) and clinical variables (tumour site and stage,
treatment modality) were assessed by medical records audit.
The Medical Ethics Committee of the VUUniversity Med-
ical Center in Amsterdam approved this study. All procedures
followed were in accordance with the Helsinki Declaration of
1975, as revised in 2008, and in accordance with local laws
and regulations.
Screening for distress
Since 2008, we offer all new HNC patients to use a touch
screen computer system (OncoQuest) to complete the HADS
and the EORTC QLQ-C30 and H&N35 HRQOL question-
naires and to consult a specialised nurse, during follow-up
visits after cancer treatment. If needed, a volunteer supports
HNC patients using the computer system. Based on the results
of OncoQuest (available in real-time in clear graphics on a
computer screen), the nurse can identify and support HNC
patients with psychological distress or problems regarding
(HNC specific) HRQOL. On average, it takes 9 min to com-
plete OncoQuest and the consultations with the nurse are es-
timated to take 10 min [7, 22, 23].
The HADS is a 14-item self-assessment scale for measuring
distress (total HADS score (HADS-T)) with two subscales,
anxiety (HADS-A) and depression (HADS-D). The HADS
was specifically designed for use in the medically ill [31].
The total HADS score ranges from 0 to 42, the subscales from
0 to 21. A score of >7 on the anxiety scale, a score of >7 on the
depression scale and/or a total HADS score of >14 is used as
an indicator of a high level of psychological distress [31, 32].
The 30-item EORTC QLQ-C30 (version 3.0) includes a
global HRQOL scale (2 items) and comprises five functional
scales: physical functioning (5 items), role functioning (2
items), emotional functioning (4 items), cognitive functioning
(2 items) and social functioning (2 items). There are three
symptom scales (nausea and vomiting (2 items), fatigue (3
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items) and pain (2 items) and six single items relating to dys-
pnoea, insomnia, loss of appetite, constipation, diarrhoea and
financial difficulties. The scores of the QLQ-C30 are linearly
transformed to a scale of 0–100, with a higher score indicating
a higher (i.e., more positive) level of functioning or global
HRQOL, or a higher (i.e., more negative) level of symptoms
or problems [33, 34].
The EORTC QLQ-H&N35 module covers specific HNC
issues and comprises seven subscales: pain (4 items),
swallowing (5 items), senses (2 items), speech (3 items), so-
cial eating (4 items), social contact (5 items) and sexuality (2
items). There are 11 single items covering problems with
teeth, dry mouth, sticky saliva, cough, feeling ill, opening
the mouth wide, weight loss, weight gain, use of nutritional
supplements, feeding tubes, and painkillers. The scores of the
QLQ-H&N35 are linearly transformed to a scale of 0–100,
with a higher score indicating a higher (i.e., more negative)
level of symptoms or problems [35]. In the present study, the
scales and the first six single items were used.
The value of screening
In the present study, eligible HNC patients in follow-up care
with an increased level of psychological distress (HADS-T
>14, HADS-A >7, or HADS-D >7) were asked whether they
received psychiatric or psychological treatment. Based on
earlier research [7, 36], it was expected that in clinical prac-
tice, 25–30 % of HNC patients would present with psycho-
logical distress of whom the majority do not receive psycho-
logical treatment. Screening for distress in follow-up care was
defined to have added value if at least 50 % of HNC patients
diagnosed with psychological distress did not yet receive
psychological or psychiatric treatment.
To provide information on sociodemographic, clinical fac-
tors and HRQOL variables possibly associated with untreated
psychological distress, several univariate analyses were per-
formed. Chi-square tests were used to investigate whether
gender (male vs. female), tumour location (lip/oral cavity,
oropharynx, hypopharynx/larynx, other), tumour stage based
on the UICC TNM classification of malignant tumours (I, II,
II, IV), treatment modality (single treatment (surgery or radio-
therapy) vs. combination (surgery and (chemo)radiation)) or
time since treatment (1–12 months vs. >12 months) were as-
sociated with untreated psychological distress. Independent t
tests or, in case of skewness, Mann-Whitney tests were used to
investigate whether age, HADS-T, HADS-A, or HADS-D or
the EORTC QLQ-C30 and H&N35 subscales were associated
with untreated psychological distress. All analyses were per-
formed using the IBM Statistical Package for the Social Sci-
ence (SPSS) version 20 (IBM Corp., Armonk, NY, USA).
For all statistical analyses, a p value <0.05 was considered
statistically significant.
OncoQuest used by 720 HNC
patients willing to participate
Eligible HNC survivors with elevated
HADS scorea (n=137)
Excluded (n=69)
Could not be reached (n=19)
< 1 month after tumour treatment (n=18)
Palliative status (n=13)
Too little knowledge of Dutch language
(n=5)
Cognitive dysfunction (n=4)
Already in treatment for other psychiatric
disorder (n=3)
Possible recurrence of tumour (n=3)
Tumour treatment not in VU Medical
Center (n=2)
Tumour treatment too lang ago (n=1)































Fig. 1 Selection of patients
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Results
Prevalence of distress and receipt of treatment
During the study period of 37 months, OncoQuest was used
by 720 HNC patients in follow-up care, of whom 714 had
complete HADS data. Figure 1 shows the flow diagram of
the selection of patients. Among the 714 HNC patients, 206
patients screened positive for psychological distress (29 %).
Of these 206 patients, 69 patients were excluded: 19 could not
be reached, 18 were treated less than 1 month earlier, 13 were
in the palliative phase of the disease, 5 had insufficient knowl-
edge of the Dutch language, 4 had a cognitive dysfunction, 3
were currently under treatment for a psychiatric disorder other
than anxiety or depression, 3 had possible tumour recurrence,
2 had not received treatment at VU University Medical Cen-
ter, 1 had received tumour treatment too long ago, and 1 also
had another untreated malignancy.
Among the 137 HNC patients who screened positive for
psychological distress during the study period and fulfilled the
in- and exclusion criteria, 25 (18 %) received psychiatric or
psychological treatment: 10 received counselling and
psychomedication, 7 received psychomedication, 4 received
counselling, and 1 received self-help and psychomedication, 3
patients did not provide information about their treatment.
Factors related to receipt of psychological or psychiatric
treatment
Sociodemographic and clinical characteristics of the study
population (n=137) are provided in Table 1, and regarding
patient reported outcome measures (HADS, EORTC QLQ-
C30 and H&N35) in Table 2.
Receipt of psychological or psychiatric treatment (vs. no
receipt) was not significantly related to gender, age, tumour
location, tumour stage, tumour treatment and time since treat-
ment (Table 1). Receipt of psychological or psychiatric treat-
ment (vs. no receipt) was significantly related to a higher score
on the HADS total scale (19.6 vs. 16.9; p=0.019), a lower
(worse) score on the EORTC QLQ-C30 scale emotional
Table 1 Overview of
sociodemographic and clinical






care (n = 25)
p
value
N N (%) N (%)
Gender 0.92
Male 92 75 (81.5) 17 (18.5)
Female 45 37 (82.2) 8 (17.8)
Mean age (SD) 61.7 (10.1) 61.9 (9.8) 61.0 (11.1) 0.74
Tumour location 0.55
Lip/oral cavity 34 29 (85.3) 5 (14.7)
Oropharynx 36 28 (77.8) 8 (22.2)
Hypopharynx/larynx 46 36 (78.3) 10 (21.7)
Other (e.g. parotis) 21 19 (90.5) 2 (9.5)
Tumour stadium 0.31
I 32 29 (90.6) 3 (9.4)
II 28 20 (71.4) 8 (28.6)
III 31 25 (80.6) 6 (19.4)
IV 41 33 (80.5) 8 (19.5)
Unknown 5 5 (100.0) 0 (0.0)
Tumour treatment 0.99
Single 82 67 (81.7) 15 (18.3)
Surgery 23 19 (82.6) 4 (17.4)
Radiotherapy 59 48 (81.4) 11 (18.6)
Combination 55 45 (81.8) 10 (18.2)
Chemoradiation 25 21 (84.0) 4 (16.0)
Surgery and
(chemo)radiation
30 24 (80.0) 6 (20.0)
Time since treatment 0.53
1–12 months 57 48 (84.2) 9 (15.8)
>12 months 80 64 (80.0) 16 (20.0)
A p value <0.05 was considered statistically significant
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functioning (46.0 vs. 58.6; p=0.023), a higher (worse) score
on fatigue (58.2 vs. 46.4; p=0.032) and problems with sexu-
ality (44.1 vs. 34.4; p=0.043), and on the EORTC QLQ-
H&N35 scales oral pain (43.8 vs. 28.8; p=0.011) and speech
problems (37.0 vs. 25.3; p=0.042).
Discussion
The present study revealed that among HNC patients, screen-
ing for distress is valuable because of the patients who screened
positive for psychological distress (29 %); the majority (82 %)
did not yet receive treatment. This percentage of patients with
untreated distress is much higher compared to 64 % among
newly diagnosed breast cancer patients as reported by Palmer
et al. [29]. Therefore, and because two thirds of patients who
screen positive may develop a full-blown depression if left
untreated [37], we disagree with Palmer et al. and conclude that
screening for distress is beneficial among HNC patients. Our
conclusion supports the findings of Kotronoulas et al. [38],
who reported in their recent review that routine use of PROMs
increases communication about patient outcomes during con-
sultations and that PROMs are associated with improved symp-
tom control, increased supportive care, and patient satisfaction.
Table 2 Overview of outcomes on HADS, EORTC QLQ-C30 and H&N35, and test statistics of between group differences
Total sample
(N)




Mean SD t or Z df p value
HADS Depression 137 8.77 3.61 112 8.42 3.12 25 10.32 5.06 −1.80 28.19 0.082
Anxiety 135 8.64 3.64 110 8.49 3.64 25 9.28 3.65 −0.98 133.00 0.335
Total score 135 17.39 5.27 110 16.88 4.79 25 19.60 6.70 −2.37 133.00 0.019
QLQ-C30 Global quality of life 136 58.52 20.37 111 58.93 19.77 25 56.67 23.20 0.50 134.00 0.617
Physical functioning 135 70.86 21.08 110 72.42 20.28 25 64.00 23.49 1.82 133.00 0.071
Role functioning 136 60.66 29.30 111 62.76 28.15 25 51.33 32.96 1.78 134.00 0.078
Emotional functioning 137 56.27 25.08 112 58.56 23.95 25 46.00 27.86 2.299 135.00 0.023
Cognitive functioning 137 71.41 22.59 112 72.62 21.90 25 66.00 25.22 1.328 135.00 0.186
Social functioning 135 65.31 25.11 111 66.52 24.77 24 59.72 26.43 1.204 133.00 0.231
Fatigue 137 48.58 24.88 112 46.43 24.56 25 58.22 24.49 −2.172 135.00 0.03
Nausea/vomiting 137 12.53 20.19 112 11.90 20.56 25 15.33 18.58 −1.32 n.a. 0.19
Pain 137 37.47 28.57 112 35.57 28.08 25 46.00 29.77 −1.662 135.00 0.10
Dyspnoea 136 27.94 28.75 112 28.27 27.66 24 26.39 34.02 0.29 134.00 0.77
Insomnia 137 37.71 34.02 112 36.31 34.24 25 44.00 32.94 −1.022 135.00 0.31
Loss of appetite 137 29.93 33.40 112 29.46 33.41 25 32.00 33.99 −0.342 135.00 0.73
Constipation 137 18.49 26.48 112 19.94 27.75 25 12.00 18.95 −1.11 n.a. 0.27
Diarrhoea 137 9.98 21.53 112 10.71 22.47 25 6.67 16.67 −0.74 n.a. 0.46
Financial difficulties 137 20.92 28.87 112 21.73 28.55 25 17.33 30.61 −0.99 n.a. 0.32
QLQ-H&N35 Oral pain 136 31.43 26.45 112 28.79 25.16 24 43.75 29.31 −2.565 134.00 0.01
Swallowing problems 136 31.62 28.29 112 29.99 28.26 24 39.24 27.75 −1.46 134.00 0.15
Senses problems 136 28.06 27.79 112 28.72 27.51 24 25.00 29.49 0.594 134.00 0.55
Speech problems 136 27.37 25.69 112 25.30 24.61 24 37.04 28.88 −2.055 134.00 0.04
Trouble with social eating 134 34.08 30.36 110 31.74 28.86 24 44.79 35.17 −1.927 132.00 0.06
Trouble with social contact 135 17.93 19.77 111 16.04 17.32 24 26.67 27.31 −1.48 n.a. 0.14
Less sexuality 132 40.15 36.89 109 36.54 34.36 23 57.25 44.05 −2.122 27.918 0.04
Teeth problems 136 24.75 31.95 112 22.62 30.42 24 34.72 37.40 −1.56 n.a. 0.12
Trouble with opening mouth 136 29.90 33.77 112 27.68 32.23 24 40.28 39.29 −1.67 134 0.10
Dry mouth 136 51.72 36.47 112 53.27 36.20 24 44.44 37.64 1.077 134 0.28
Sticky saliva 136 42.40 34.54 112 43.15 34.26 24 38.89 36.34 0.548 134 0.59
Coughing 136 33.33 29.26 112 33.04 28.47 24 34.72 33.30 −0.255 134 0.80
Feeling ill 136 30.64 30.91 112 28.87 30.18 24 38.89 33.57 −1.447 134 0.5
In some cases, the total group was smaller than 137 because of missing values
No PC received no psychosocial care, PC received psychosocial care, SD standard deviation, n.a. not applicable
A p value <00.05 was considered statistically significant
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Receipt of psychological or psychiatric treatment was sig-
nificantly related to a higher score on the HADS total scale, a
lower (worse) score on the EORTCQLQ-C30 scale emotional
functioning, a higher (worse) score on fatigue and problems
with sexuality, and on the EORTC QLQ-H&N35 scales oral
pain and speech problems. An explanation for these findings
might be that patients with more severe problems are more
inclined to seek help. But also, these patients might be detect-
ed easier by caregivers during follow-up consultation and
therefore are referred to supportive care earlier. Carlson et al.
reported that full screening (online use of PROMs with a
personalised printout of results and a list of contact details of
services to help with the identified problems) and triage to
care (full screening plus the opportunity to speak with a care
professional who could refer to services directly) both result in
the most benefit for lung cancer patients, compared to screen-
ing alone. Fewer patients in the triage group reported a prob-
lem with coping (12.9 %) compared with patients in the min-
imal (23.9 %) and full (26.9 %) screening groups [26]. Mitch-
ell concluded that screening for distress and monitoring
HRQOL in clinical practice is likely to benefit communication
and referral for psychosocial help, and that, it has the potential
to influence patient well-being but only if barriers are ad-
dressed [16]. However, understanding about the complexities
of implementing screening programs is still unfolding [15]. In
earlier studies, it was argued that incorporating PROMs in
clinical practice should aim at equipping health professionals
to use patient PROMs data in managing patients, should em-
ploy more condition-specific (rather than generic) PROMs,
should improve the interpretability of the PROM data feed-
back to both medical staff and patients, and should support
patients to improve their self-efficacy to manage illness-
related issues [39]. Recently, key barriers were identified as
lack of training and support, low acceptability, and failure to
link treatment to the screening results [16]. Also, further im-
plementation research is needed to advance knowledge about
the most effective strategies in the context of cancer care [27].
A limitation to our study is that we missed information
about the receipt of psychosocial care for 10 % of the partic-
ipating HNC patients because they could not be reached.
However, these patients had mainly borderline HADS scores
and additional information about referral to psychological ser-
vices was not present in their medical dossiers. Therefore,
these patients are suspected to not have received any psycho-
social treatment. Another limitation of the study is that we do
not know whether patients, who did receive treatment, did so
as a result of distress screening or whether they already re-
ceived such treatment. Furthermore, we do not know how
many patients, who did not receive psychological treatment
or psychiatric treatment (82 %), had unmet psychological care
needs. Based on earlier research [40, 41] and clinical practice,
our estimation is that many patients with psychological dis-
tress do not want to be referred to psychological care. This was
the main reason to start a trial on stepped care in which pa-
tients are offered low-intensity interventions like self-help
first, before being referred to a psychologist or psychiatrist
[42]. Although OncoQuest is valued by the coordinating nurse
and by patients, not all eligible patients make use of
OncoQuest, which may have resulted in selection bias. A
mixed method study including qualitative and quantitative
research measures is ongoing and will provide detailed insight
into possible barriers and facilitators enabling optimization of
OncoQuest. In their randomised clinical trial, Carlson et al.
[43], examining the impact of screening for distress followed
by personalised triage versus computerised triage, concluded
that the best model of screening may be to incorporate
personalised triage for patients indicating high levels of de-
pression and anxiety while providing computerised triage for
others. Further research is needed on best-practice approaches
for implementing sustainable and acceptable screening for
distress and triage programs in clinical settings.
Conclusion
Screening for psychological distress among HNC patients is
beneficial to identify patients with psychological distress who
do not yet receive treatment. Via OncoQuest, a broad spec-
trum of HRQOL is monitored (EORTC QLQ-C30 and QLQ-
HN35module), enabling identification of not only psycholog-
ical distress but also of other problems.
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